Literature DB >> 24384812

An overview of MYC and its interactome.

Maralice Conacci-Sorrell1, Lisa McFerrin, Robert N Eisenman.   

Abstract

This review is intended to provide a broad outline of the biological and molecular functions of MYC as well as of the larger protein network within which MYC operates. We present a view of MYC as a sensor that integrates multiple cellular signals to mediate a broad transcriptional response controlling many aspects of cell behavior. We also describe the larger transcriptional network linked to MYC with emphasis on the MXD family of MYC antagonists. Last, we discuss evidence that the network has evolved for millions of years, dating back to the emergence of animals.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24384812      PMCID: PMC3869278          DOI: 10.1101/cshperspect.a014357

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  238 in total

1.  Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.

Authors:  C Bouchard; O Dittrich; A Kiermaier; K Dohmann; A Menkel; M Eilers; B Lüscher
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

2.  Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.

Authors:  Masayoshi Yada; Shigetsugu Hatakeyama; Takumi Kamura; Masaaki Nishiyama; Ryosuke Tsunematsu; Hiroyuki Imaki; Noriko Ishida; Fumihiko Okumura; Keiko Nakayama; Keiichi I Nakayama
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

Review 3.  Making myc.

Authors:  J Liu; D Levens
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

4.  Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain.

Authors:  A R Ferré-D'Amaré; G C Prendergast; E B Ziff; S K Burley
Journal:  Nature       Date:  1993-05-06       Impact factor: 49.962

5.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

6.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors:  G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

7.  High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations.

Authors:  Jennifer Edelmann; Karlheinz Holzmann; Florian Miller; Dirk Winkler; Andreas Bühler; Thorsten Zenz; Lars Bullinger; Michael W M Kühn; Andreas Gerhardinger; Johannes Bloehdorn; Ina Radtke; Xiaoping Su; Jing Ma; Stanley Pounds; Michael Hallek; Peter Lichter; Jan Korbel; Raymonde Busch; Daniel Mertens; James R Downing; Stephan Stilgenbauer; Hartmut Döhner
Journal:  Blood       Date:  2012-10-09       Impact factor: 22.113

Review 8.  The c-myc promoter: still MysterY and challenge.

Authors:  Inken Wierstra; Jürgen Alves
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

9.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.

Authors:  M M Nau; B J Brooks; J Battey; E Sausville; A F Gazdar; I R Kirsch; O W McBride; V Bertness; G F Hollis; J D Minna
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

10.  N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc.

Authors:  H Rosenbaum; E Webb; J M Adams; S Cory; A W Harris
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

View more
  169 in total

1.  Deubiquitinating c-Myc: USP36 steps up in the nucleolus.

Authors:  Xiao-Xin Sun; Rosalie C Sears; Mu-Shui Dai
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  Transcription Factor Inhibition: Lessons Learned and Emerging Targets.

Authors:  Andrew Chen; Angela N Koehler
Journal:  Trends Mol Med       Date:  2020-02-15       Impact factor: 11.951

Review 3.  MYC and transcription elongation.

Authors:  Peter B Rahl; Richard A Young
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 4.  The role of MIZ-1 in MYC-dependent tumorigenesis.

Authors:  Katrin E Wiese; Susanne Walz; Björn von Eyss; Elmar Wolf; Dimitris Athineos; Owen Sansom; Martin Eilers
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

Review 5.  Taking on challenging targets: making MYC druggable.

Authors:  Dai Horiuchi; Brittany Anderton; Andrei Goga
Journal:  Am Soc Clin Oncol Educ Book       Date:  2014

6.  Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis.

Authors:  Patrick A Carroll; Daniel Diolaiti; Lisa McFerrin; Haiwei Gu; Danijel Djukovic; Jianhai Du; Pei Feng Cheng; Sarah Anderson; Michelle Ulrich; James B Hurley; Daniel Raftery; Donald E Ayer; Robert N Eisenman
Journal:  Cancer Cell       Date:  2015-01-29       Impact factor: 31.743

7.  Synthetic molecules for disruption of the MYC protein-protein interface.

Authors:  Nicholas T Jacob; Pedro O Miranda; Ryan J Shirey; Ritika Gautam; Bin Zhou; M Elena de Orbe Izquierdo; Mark S Hixon; Jonathan R Hart; Lynn Ueno; Peter K Vogt; Kim D Janda
Journal:  Bioorg Med Chem       Date:  2018-07-11       Impact factor: 3.641

Review 8.  The MYC-WDR5 Nexus and Cancer.

Authors:  Lance R Thomas; Audra M Foshage; April M Weissmiller; William P Tansey
Journal:  Cancer Res       Date:  2015-09-17       Impact factor: 12.701

Review 9.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

10.  MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation.

Authors:  Sarah Anderson; Kumud Raj Poudel; Minna Roh-Johnson; Thomas Brabletz; Ming Yu; Nofit Borenstein-Auerbach; William N Grady; Jihong Bai; Cecilia B Moens; Robert N Eisenman; Maralice Conacci-Sorrell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.